Conversation about acquiring DPT, the future of CDMOs and more

Contract Pharma interviewed Pierre Frechette, president and chief executive officer of Renaissance Pharma to discuss the process of buying DPT, his group’s philosophy regarding acquisitions and operations, and DPT’s synergies with another recent acquisition.

Read More at Contract Pharma